FDA OKs First Targeted Agent, Pemigatinib, for Rare Blood Cancer
The new indication for pemigatinib makes it the only available targeted treatment for myeloid/lymphoid neoplasms with FGFR1 rearrangement.
Source: medscape.com
Page 39 - Hematologic Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hematologic Malignancies Today - Breaking & Trending Today
FDA Lifts Partial Clinical Hold on the TakeAim Lymphoma Study of Emavusertib
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
Source: prnewswire.com
AML's Seasonal Peak Suggests Viral or Environmental Etiology
The finding that most diagnoses of acute myeloid leukemia are made during January raises the possibility that the cancer results from infectious or environmental agents.
Source: medscape.com
OneOncology Offers Support for Community Oncology Clinics
OneOncology is a physician-driven group helping to keep community practices in business and helping them to expand community-based oncology care.
Source: medscape.com
University of Kansas Health System cancer care floors foster community and empathy
On three floors of Cambridge Tower A at The University of Kansas Health System in Kansas City, patients being treated for blood cancers have a dedicated space that not only keeps them safe during immune system comprising treatments, but also provide feelings of comfort and compassion.
Source: bdcnetwork.com